Clinical trial
Milnacipran for the Pain, Sensory Sensitization and Mood Changes in Knee Osteoarthritis
NCT01510457 is registered in ClinicalTrials.gov with Dr. Norman Harden as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Milnacipran for the Pain, Sensory Sensitization and Mood Changes in Knee Osteoarthritis
- Lead sponsor
- Dr. Norman Harden
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- October 31, 2013
- Enrollment
- 46 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pain, degenerative joint disease, knee osteoarthritis